ClinicalTrials.Veeva

Menu

The Effect of Remote Ischemic Preconditioning on Kidney Function in Patients Undergoing Partial Nephrectomy

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Renal Neoplasm
Renal Injury

Treatments

Procedure: Remote Ischemic Preconditioning
Procedure: Sham control

Study type

Interventional

Funder types

Other

Identifiers

NCT03273751
1707-087-870

Details and patient eligibility

About

This study is intended to evaluate the renal protective effect of Remote Ischemic Preconditioning (RIPC) in patients undergoing partial nephrectomy. Half of the enrolled subjects will receive 4 cycles of brief ischemia on the upper arm after anesthesia induction and prior to the surgery, while the other half will not receive this treatment as a control group.

Full description

Remote Ischemic Preconditioning (RIPC) is the concept of mitigating ischemia-reperfusion injury to target organs by a brief episode of ischemia-reperfusion of the limb. The protective effect of RIPC on major organs has been demonstrated in an animal study, but its clinical efficacy has not yet been established.

The kidney is a typical organ vulnerable to ischemic injury, and the renal protective effect of RIPC can be expected. There have been many reports of renal protective effects of RIPC in cardiac and vascular surgery. On the other hand, few studies have investigated the effect of RIPC during partial nephrectomy in which ischemia-reperfusion injury can occur during the surgery.

In this study, the investigators will evaluate the effect of RIPC in patients undergoing partial nephrectomy to prevent renal impairment and improve the prognosis after the surgery.

Enrollment

86 patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients scheduled to undergo open, laparoscopic, or robot-assisted laparoscopic partial nephrectomy
  • Normal contralateral renal function was defined as split renal function of >40% as determined by preoperative Tc-99m DiethyleneTriamine Pentaacetic Acid (DTPA) kidney scan
  • Written informed consent

Exclusion criteria

  • Peripheral vascular disease involving upper extremities or lower extremities
  • Severe cardiopulmonary diseases (valvular or ischemic heart disease, heart failure, chronic obstructive pulmonary disease)
  • Hepatic failure, renal failure

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

86 participants in 2 patient groups

Remote Ischemic Preconditioning (RIPC)
Experimental group
Description:
Four cycles of upper arm ischemia/reperfusion
Treatment:
Procedure: Remote Ischemic Preconditioning
Sham control
Sham Comparator group
Description:
Placement of a blood pressure cuff around upper arm without inflation.
Treatment:
Procedure: Sham control

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems